Haberler

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate

Amphastar (AMPH) passes quality screen with 17.2% ROIC, 104% profit quality, and cheap valuation, but revenue growth lags.

ChartMill·20 gün önce·AMPH